aTYR PHARMA INC Other Non-Current Liabilities
aTYR PHARMA INC (ATYR) had Other Non-Current Liabilities of $557.00 thousand as of 2016-03-31, per its 10-Q filed 2016-05-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2017-03-16
- 2016-03-31: Other Liabilities, Noncurrent $557.00K.
- 2015-12-31: Other Liabilities, Noncurrent $571.00K.
- 2015-09-30: Other Liabilities, Noncurrent $585.00K.
- 2015-06-30: Other Liabilities, Noncurrent $588.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2016-03-31 | $557.00K 10-Q · filed 2016-05-11 |
| 2015-12-31 | $571.00K 10-K · filed 2017-03-16 |
| 2015-09-30 | $585.00K 10-Q · filed 2015-11-10 |
| 2015-06-30 | $588.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $380.00K 10-Q · filed 2015-06-18 |
| 2014-12-31 | $335.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |